Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Healthtrust
Harvard Business School
McKesson
Johnson and Johnson
Deloitte
US Department of Justice
Chinese Patent Office

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021267

« Back to Dashboard

NDA 021267 describes VFEND, which is a drug marketed by Pf Prism Cv and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug and three Paragraph IV challenges. Additional details are available on the VFEND profile page.

The generic ingredient in VFEND is voriconazole. There are fourteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the voriconazole profile page.
Summary for 021267
Tradename:VFEND
Applicant:Pf Prism Cv
Ingredient:voriconazole
Patents:1
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021267
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VFEND voriconazole INJECTABLE;IV (INFUSION) 021267 NDA Roerig 0049-3190 N 0049-3190-28
VFEND voriconazole INJECTABLE;IV (INFUSION) 021267 NDA Roerig 0049-3190 N 0049-3190-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)Strength200MG/VIAL
Approval Date:May 24, 2002TE:APRLD:Yes
Patent:➤ Sign UpPatent Expiration:Jun 2, 2018Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021267

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv VFEND voriconazole INJECTABLE;IV (INFUSION) 021267-001 May 24, 2002 ➤ Sign Up ➤ Sign Up
Pf Prism Cv VFEND voriconazole INJECTABLE;IV (INFUSION) 021267-001 May 24, 2002 ➤ Sign Up ➤ Sign Up
Pf Prism Cv VFEND voriconazole INJECTABLE;IV (INFUSION) 021267-001 May 24, 2002 ➤ Sign Up ➤ Sign Up
Pf Prism Cv VFEND voriconazole INJECTABLE;IV (INFUSION) 021267-001 May 24, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Johnson and Johnson
AstraZeneca
Teva
Medtronic
Boehringer Ingelheim
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.